Zobrazeno 1 - 10
of 72
pro vyhledávání: '"Eran, Hadas"'
Autor:
Boe-Hyun Kim, Eran Hadas, Jennifer Kelschenbach, Wei Chao, Chao-Jiang Gu, Mary Jane Potash, David J. Volsky
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-13 (2023)
Abstract HIV enters the brain within days of infection causing neurocognitive impairment (NCI) in up to half of infected people despite suppressive antiretroviral therapy. The virus is believed to enter the brain in infected monocytes through chemota
Externí odkaz:
https://doaj.org/article/bc0bc38fa5a3440cac15f2ef92457fdc
Publikováno v:
Viruses, Vol 16, Iss 5, p 693 (2024)
Background. EcoHIV is a chimeric HIV that replicates in mice in CD4+ T cells, macrophages, and microglia (but not in neurons), causing lasting neurocognitive impairment resembling neurocognitive disease in people living with HIV. The present study wa
Externí odkaz:
https://doaj.org/article/42803026dcbb44a69cbf016bca261017
Autor:
Chao-Jiang Gu, Alejandra Borjabad, Eran Hadas, Jennifer Kelschenbach, Boe-Hyun Kim, Wei Chao, Ottavio Arancio, Jin Suh, Bruce Polsky, JoEllyn McMillan, Benson Edagwa, Howard E Gendelman, Mary Jane Potash, David J Volsky
Publikováno v:
PLoS Pathogens, Vol 14, Iss 6, p e1007061 (2018)
Suppression of HIV replication by antiretroviral therapy (ART) or host immunity can prevent AIDS but not other HIV-associated conditions including neurocognitive impairment (HIV-NCI). Pathogenesis in HIV-suppressed individuals has been attributed to
Externí odkaz:
https://doaj.org/article/3593da4864114c1e82e78c8b2f270cc6
Autor:
Eran Hadas, Wei Chao, Hongxia He, Manisha Saini, Eleen Daley, Mohammed Saifuddin, Galina Bentsman, Eric Ganz, David J. Volsky, Mary Jane Potash
Publikováno v:
Disease Models & Mechanisms, Vol 6, Iss 5, Pp 1292-1298 (2013)
SUMMARY Heterosexual transmission accounts for the majority of new human immunodeficiency virus (HIV) cases worldwide. The current approach to investigate HIV heterosexual transmission in animals involves application of virus stock to the vaginal sur
Externí odkaz:
https://doaj.org/article/833e83fe11e443b59941b467f381a6e1
Autor:
Michael T. Nedelcovych, David J. Volsky, Eran Hadas, Justin C. McArthur, Alejandra Borjabad, Mary Jane Potash, Barbara S. Slusher, Norman J. Haughey, Boe-Hyun Kim, Hongxia He, Rana Rais, Jennifer Kelschenbach
Publikováno v:
AIDS (London, England)
Supplemental Digital Content is available in the text
Objective: Almost half of HIV-positive people on antiretroviral therapy have demonstrable mild neurocognitive impairment (HIV-NCI), even when virologically suppressed. Intranasal insulin ther
Objective: Almost half of HIV-positive people on antiretroviral therapy have demonstrable mild neurocognitive impairment (HIV-NCI), even when virologically suppressed. Intranasal insulin ther
Autor:
Eran Hadas
Publikováno v:
The Routledge Handbook of Remix Studies and Digital Humanities ISBN: 9780429355875
The Routledge Handbook of Remix Studies and Digital Humanities
The Routledge Handbook of Remix Studies and Digital Humanities
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d2db790111253ebdb9c3126fd4e70689
https://doi.org/10.4324/9780429355875-19
https://doi.org/10.4324/9780429355875-19
Publikováno v:
Disease Models & Mechanisms, Vol 7, Iss 2, Pp 178-179 (2014)
Externí odkaz:
https://doaj.org/article/777e67fe94c1429ba9854d46386c4d30
Autor:
Patrick Geraghty, Boe-Hyun Kim, Robert F. Foronjy, David J. Volsky, Abdoulaye J. Dabo, Eran Hadas
Publikováno v:
American Journal of Physiology-Lung Cellular and Molecular Physiology. 312:L500-L509
Cigarette smoke usage is prevalent in human immunodeficiency virus (HIV)-positive patients, and, despite highly active antiretroviral therapy, these individuals develop an accelerated form of chronic obstructive pulmonary disease (COPD). Studies inve
Autor:
Loreto Carvallo, Lydia Tesfa, Joan W. Berman, David J. Volsky, Monica Rivera-Mindt, Chinazo O. Cunningham, Aniella Murphy, Matías Jaureguiberry-Bravo, Eran Hadas, Julia H. Arnsten, Jennifer Kelschenbach, Travis M Scott
Publikováno v:
J Leukoc Biol
Approximately 15–40% of people living with HIV develop HIV-associated neurocognitive disorders, HAND, despite successful antiretroviral therapy. There are no therapies to treat these disorders. HIV enters the CNS early after infection, in part by t